Skip to main content
. 2022 Feb 16;8(7):eabm1418. doi: 10.1126/sciadv.abm1418

Fig. 2. Physicochemical property characterization of iLAND and its cellular uptake behavior.

Fig. 2.

(A) Physicochemical property characterization of iLAND before and after siRNA encapsulation, which includes the size, PDI, zeta potential, encapsulation efficiency (E.E.), and loading efficiency (L.E.). (B) TEM image of siRNA@iLAND. (C) TNS was used for pKa determination, and the pKa of iLAND was approximately 6.16. (D) Cell viabilities of siRNA@iLAND were evaluated by using HepG2 cells. n = 6. (E) Chemical stability of A1-D1-5 and (F) formulation stability of siRNA@iLAND. RT, room temperature. (G) Cellular uptake and (H) the MFI of siRNA@iLAND, comparison with siRNA@Lipo. (I) Subcellular localization of siRNA@iLAND or siRNA@Lipo2000. ns, not significant.